Post by Sobi - Swedish Orphan Biovitrum AB (publ)

Name: We are pleased to share a strong start to the year, with our portfolio continuing to demonstrate the
Uploaded: 2026-04-28T06:50:45.685Z
Channel: Sobi - Swedish Orphan Biovitrum AB (publ)
Description: We are pleased to share a strong start to the year, with our portfolio continuing to demonstrate the value we bring to people living with rare diseases. “Our solid performance was driven by successfu

153,573 followers

We are pleased to share a strong start to the year, with our portfolio continuing to demonstrate the value we bring to people living with rare diseases. “Our solid performance was driven by successful launches and progress across our pipeline, including new indications and regulatory submissions in Europe,” says Guido Oelkers, President & CEO. At Sobi, performance is about more than numbers - it’s about making a real difference. Our Q1 results reflect the strength of our science, the dedication of our people, and our commitment to improving access to treatments for those who need them. Learn more about Sobi and read the full Q1 report on our website. #Sobi #RareDiseases #InvestorRelations

Video Content